Research for a Future
without Diabetes

„Research for a future without diabetes – this is the mission of the DZD that inspires and unites us.“

Prof. Martin Hrabě de Angelis, DZD board member

Research for a Future
without Diabetes

"The DZD stands for research to benefit people with diabetes."

Prof. Andreas Birkenfeld, DZD-Sprecher

„The Germany-wide cooperation in the DZD ensures that multicenter studies can be carried out with the required number of participants.“

Prof. Michael Roden, DZD board member

 

Research for a Future
without Diabetes

„The DZD places particular importance on the fast transfer of lab results to patient care.“

Prof. Michele Solimena, DZD speaker

 

 

Research for a Future
without Diabetes

„The special feature of research at the DZD is the close interdisciplinary cooperation between different disciplines.“

Prof. Annette Schuermann, DZD Speaker

DZD - German Center
for Diabetes Research

Neuherberg, 03.09.2021

DZD Annual Report Published: Targeted Promotion of Young Talent

The German Center for Diabetes Research (DZD) has published its 2020 Annual Report. On 64 pages, the DZD not only presents current figures, data, and facts but also provides information about the latest developments in translational diabetes research. A primary focus is the promotion of young talent.  

The annual report offers an insight into the multifaceted scientific work of the DZD as well as selected highlights of the year 2020. The report pays special attention to the promotion of young scientists of the DZD. The DZD NEXT program helps young researchers to further their education, to develop networks and to take the next steps in their careers. In this way, the DZD also contributes to making Germany an attractive location for young scientists. In three short interviews, researchers report on how they have benefited from the program. 

Another focus is the presentation of research highlights: DZD researchers have succeeded in identifying subtypes already in a preliminary stage of diabetes (prediabetes). This provides a key basis for the development of precise diabetes prevention and therapy. DZD studies show that the function of insulin-producing beta cells already deteriorates at an early stage of type 2 diabetes development. DZD scientists were able to restore beta cell function in an animal model with the aid of a new combination of active compounds. 

Type 1 diabetes is the most common metabolic disease in children and adolescents. DZD scientists are conducting intensive research on this autoimmune disease. Screening for islet autoantibodies makes it possible for the first time to diagnose the disease before the first symptoms of type 1 diabetes appear (pre-symptomatic stages). 

Other topics covered in the annual report include the main research areas (academies), the expansion of the research infrastructure, the current status of multicenter studies, highlights from public relations work, and current figures and data from the DZD. 

The 2020 Annual Report is published in German and English and is available online and for download on the DZD website.  

© DZD

Press contact

Birgit Niesing


+49 (0)89 3187-3971